In agreement with robust TGFBR1 and TGFBR2 expression in lymphocytes of the metastatic lesions, our spatial ligand-receptor analysis revealed active immunosuppressive TGFβ signaling50 mediated by tumor cells targeted lymphocyte populations (Fig. 7H). Here, TGFBR2 is linked to neoplasm.